The chemical class known as Gpr165 Activators encompasses a range of compounds specifically designed to enhance or stimulate the activity of the Gpr165 protein. Gpr165, identified through extensive molecular and genomic research, is a G-protein coupled receptor (GPCR) known to play a critical role in a variety of cellular processes. The functionality of Gpr165 is essential in cellular signaling pathways, where it acts as a mediator for various biological responses. The activators targeting Gpr165 are developed with the objective of binding to this receptor and promoting its activity. This activation is crucial as it facilitates the receptor's ability to transmit signals, thereby influencing the biochemical pathways in which Gpr165 is involved. By stimulating the activity of Gpr165, these activators are designed to amplify the associated cellular processes, potentially affecting specific cellular functions and mechanisms.
The development of Gpr165 Activators is a complex and interdisciplinary endeavor, involving the integration of molecular biology, medicinal chemistry, and pharmacology. The initial phase of this development process involves attaining a deep understanding of the structure and function of the Gpr165 protein. Advanced techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational molecular modeling are utilized to gain a detailed perspective of the receptor. This foundational knowledge is critical for the rational design of activators that are effective in their interaction with Gpr165 and exhibit a high degree of specificity. Typically, these activators are small molecules or peptides, designed to efficiently interact with the receptor and induce its activation. The molecular design of these activators is carefully optimized to ensure robust interactions with Gpr165, often involving specific binding sites and conformational changes that trigger receptor activation. The efficacy of these activators is evaluated through various biochemical and cellular assays in vitro and in cellular models. These assays are essential for determining the activators' potency, specificity, and overall impact on Gpr165 signaling pathways, providing key insights into their behavior and mechanism of action. Such research is fundamental for understanding the potential of Gpr165 Activators in modulating cellular processes and for further exploration into their implications in cellular signaling and function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This compound is a DNA methyltransferase inhibitor that may lead to the demethylation of gene promoters, potentially resulting in gene activation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can lead to a more open chromatin structure, potentially increasing gene transcription. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can modulate gene expression by activating retinoic acid receptors, which act as transcription factors for various genes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C, which can lead to the activation of downstream signaling pathways affecting gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor that can increase histone acetylation, potentially enhancing gene expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid is another histone deacetylase inhibitor that may lead to chromatin remodeling and activation of some genes. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
Theophylline is a phosphodiesterase inhibitor that may lead to increased cAMP levels, potentially affecting gene transcription. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-estradiol binds to estrogen receptors, which may regulate gene transcription upon binding to DNA response elements. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can inhibit GSK-3, potentially leading to the activation of Wnt signaling and affecting gene expression. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG interferes with Hsp90’s chaperone function, which may lead to the destabilization of client proteins and alter gene expression. | ||||||